AmerisourceBergen Corp. (ABC) Shares Sold by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. reduced its position in AmerisourceBergen Corp. (NYSE:ABC) by 5.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,201 shares of the company’s stock after selling 1,533 shares during the period. Crossmark Global Holdings Inc.’s holdings in AmerisourceBergen were worth $2,406,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its stake in AmerisourceBergen by 107.3% during the third quarter. JPMorgan Chase & Co. now owns 5,363,429 shares of the company’s stock worth $434,385,000 after acquiring an additional 2,776,287 shares during the last quarter. Harding Loevner LP increased its stake in AmerisourceBergen by 89.6% during the third quarter. Harding Loevner LP now owns 3,166,794 shares of the company’s stock worth $134,939,000 after acquiring an additional 1,496,761 shares during the last quarter. Point72 Asset Management L.P. bought a new stake in AmerisourceBergen during the third quarter worth approximately $75,681,000. Beutel Goodman & Co Ltd. increased its stake in AmerisourceBergen by 23.3% during the fourth quarter. Beutel Goodman & Co Ltd. now owns 2,374,727 shares of the company’s stock worth $174,194,000 after acquiring an additional 449,330 shares during the last quarter. Finally, Wells Fargo & Company MN increased its stake in AmerisourceBergen by 11.4% during the third quarter. Wells Fargo & Company MN now owns 3,726,377 shares of the company’s stock worth $308,358,000 after acquiring an additional 381,936 shares during the last quarter. Institutional investors own 66.84% of the company’s stock.

In other news, Chairman Steven H. Collis sold 21,350 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $98.58, for a total transaction of $2,104,683.00. Following the transaction, the chairman now owns 287,925 shares of the company’s stock, valued at $28,383,646.50. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Peyton R. Howell sold 3,000 shares of the stock in a transaction that occurred on Wednesday, February 7th. The stock was sold at an average price of $91.60, for a total value of $274,800.00. Following the completion of the transaction, the insider now directly owns 49,189 shares in the company, valued at approximately $4,505,712.40. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 203,077 shares of company stock worth $18,288,730. Insiders own 27.30% of the company’s stock.

ABC has been the topic of several analyst reports. Credit Suisse Group reissued an “outperform” rating and set a $112.00 price objective (up from $105.00) on shares of AmerisourceBergen in a research note on Wednesday, February 7th. They noted that the move was a valuation call. Needham & Company LLC boosted their price objective on AmerisourceBergen from $86.00 to $88.00 and gave the stock a “buy” rating in a research note on Wednesday, November 22nd. Mizuho set a $100.00 price objective on AmerisourceBergen and gave the stock a “hold” rating in a research note on Wednesday, January 24th. Robert W. Baird reissued a “buy” rating and set a $96.00 price objective on shares of AmerisourceBergen in a research note on Monday, November 6th. Finally, TheStreet raised AmerisourceBergen from a “c” rating to a “b” rating in a research note on Tuesday, February 6th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. AmerisourceBergen presently has a consensus rating of “Buy” and a consensus target price of $101.17.

AmerisourceBergen Corp. (ABC) opened at $89.19 on Monday. The company has a market capitalization of $19,592.28, a P/E ratio of 19.22, a PEG ratio of 1.43 and a beta of 1.02. AmerisourceBergen Corp. has a 52 week low of $71.90 and a 52 week high of $106.27. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.50 and a current ratio of 0.95.

AmerisourceBergen (NYSE:ABC) last released its earnings results on Tuesday, February 6th. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.35 by $0.20. The firm had revenue of $40.47 billion for the quarter, compared to analysts’ expectations of $40.42 billion. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The company’s quarterly revenue was up 6.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.36 earnings per share. sell-side analysts forecast that AmerisourceBergen Corp. will post 6.58 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 5th. Stockholders of record on Tuesday, February 20th will be paid a dividend of $0.38 per share. The ex-dividend date of this dividend is Friday, February 16th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.70%. AmerisourceBergen’s dividend payout ratio is 32.76%.

ILLEGAL ACTIVITY NOTICE: “AmerisourceBergen Corp. (ABC) Shares Sold by Crossmark Global Holdings Inc.” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.com-unik.info/2018/02/12/amerisourcebergen-corp-abc-shares-sold-by-crossmark-global-holdings-inc.html.

About AmerisourceBergen

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit